L, R., GG, K., CH, L., SA, C., S, P., NV, U., . . . PA, P. (2025). Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group. JCO precision oncology, 9, e2400489. https://doi.org/10.1200/PO-24-00489
Chicago Style (17th ed.) CitationL, Rajdev, et al. "Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group." JCO Precision Oncology 9 (2025): e2400489. https://doi.org/10.1200/PO-24-00489.
MLA (9th ed.) CitationL, Rajdev, et al. "Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group." JCO Precision Oncology, vol. 9, 2025, p. e2400489, https://doi.org/10.1200/PO-24-00489.